Bifidobacterium longum

Bifidobacterium longum is a beneficial bacterium found in the human gut that plays a crucial role in maintaining digestive health and has been studied for its potential therapeutic effects. Research indicates that Bifidobacterium longum can protect against inflammatory bowel disease by modulating immune responses and reducing inflammation. It also shows promise in improving atopic dermatitis through tryptophan metabolism, which influences the gut-skin axis. Additionally, this bacterium has been found to enhance liver function recovery after surgery for hepatocellular carcinoma and alleviate symptoms of diarrhea-predominant irritable bowel syndrome.

Bifidobacterium longum's ability to modulate the gut microbiota and reduce inflammation is a key mechanism underlying its therapeutic benefits. The use of Bifidobacterium longum, both live and heat-treated, has been evaluated in clinical trials for safety and efficacy, with positive outcomes reported. Artificial enzymes combined with Bifidobacterium longum have also shown potential in treating intestinal inflammation and microbiota dysbiosis.

While these findings highlight the diverse benefits of Bifidobacterium longum, more research is needed to fully understand its mechanisms and optimal applications.

Sources

• Bifidobacterium Longum: Protection against Inflammatory Bowel Disease. (PMID:34337079)
• Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond. (PMID:36896934)
• Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis. (PMID:35239463)
• Bifidobacterium longum promotes postoperative liver function recovery in patients with hepatocellular carcinoma. (PMID:38091982)
• A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome. (PMID:38630015)
• Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis. (PMID:36973397)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._